Sun Pharma Advanced Research Company informs about company updates

09 Dec 2019 Evaluate

Pursuant to regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015 and further to letter No. SPARC/Sec/SE/2019-20/027 dated 20th August 2019, Sun Pharma Advanced Research Company has informed that, Abraxis Biosciences LLC has dismissed the patent infringement complaint filed against SPARC regarding SPARCs New Drug Application for PICS (Paclitaxel Injection Concentrate for Suspension).

The above information is a part of company’s filings submitted to BSE.

Sun Pharma Adv. Res Share Price

204.40 14.00 (7.35%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 869.40
Sagility India 28.03
AGS Transact Tech 79.99
Just Dial 1073.50
Krystal Integrated 643.20
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.